Molina Healthcare (NYSE:MOH) Releases FY 2025 Earnings Guidance

Molina Healthcare (NYSE:MOH) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 24.500- for the period, compared to the consensus EPS estimate of 26.070. The company issued revenue guidance of -.

Molina Healthcare Stock Performance

MOH traded up $2.04 during midday trading on Wednesday, hitting $317.45. 806,764 shares of the company were exchanged, compared to its average volume of 577,415. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53. Molina Healthcare has a 1-year low of $272.69 and a 1-year high of $423.92. The company’s 50 day simple moving average is $298.78 and its 200 day simple moving average is $318.38. The firm has a market capitalization of $18.16 billion, a price-to-earnings ratio of 16.12, a price-to-earnings-growth ratio of 0.96 and a beta of 0.54.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. As a group, sell-side analysts predict that Molina Healthcare will post 23.44 earnings per share for the current year.

Analyst Upgrades and Downgrades

MOH has been the topic of several recent research reports. Barclays upped their target price on shares of Molina Healthcare from $359.00 to $372.00 and gave the stock an “equal weight” rating in a research note on Friday, October 25th. StockNews.com raised Molina Healthcare from a “buy” rating to a “strong-buy” rating in a report on Friday, January 31st. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and set a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, October 24th. Finally, Truist Financial decreased their price target on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $359.18.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.